Company: Johnson & Johnson
Ticker: JNJ
Form: 10-K
Filed: 2026-02-11
Fiscal Period: {"fp": "FY", "fy_curr": 2025, "fy_prev": 2024}

Question: By what percentage did Johnson & Johnson's net income change from fiscal year 2024 to fiscal year 2025?
Question Type: temporal_comparison

Concept: NetIncomeLoss
Answer (Numeric): 90.56
Answer (Display): 90.56%
Unit: percent_change

Evidence:
[{"chunk_id": "102", "equivalent_chunk_ids": ["102"], "section": "Johnson & Johnson and subsidiaries consolidated statements of earnings", "supports": ["current", "previous"], "text": "(Dollars and Shares in Millions Except Per Share Amounts) (Note 1)\nSales to customers\n94,193\n88,821\n85,159\nCost of products sold\n30,256\n27,471\n26,553\nGross profit\n63,937\n61,350\n58,606\nSelling, marketing and administrative expenses\n23,676\n22,869\n21,512\nResearch and development expense\n14,665\n17,232\n15,085\nIn-process research and development impairments\nInterest income\n1,056\n1,332\n1,261\nInterest expense, net of portion capitalized (Note 4)\nOther (income) expense, net\n7,209\n4,694\n6,634\nRestructuring (Note 20)\nEarnings before provision for taxes on income\n32,581\n16,687\n15,062\nProvision for taxes on income (Note 8)\n5,777\n2,621\n1,736\nNet earnings from continuing operations\n26,804\n14,066\n13,326\nNet earnings from discontinued operations, net of tax (Note 21)\n21,827\nNet earnings\n26,804\n14,066\n35,153\nNet earnings per share (Notes 1 and 15)\nContinuing operations - basic\n11.13\n5.84\n5.26\nDiscontinued operations - basic\n8.62\nTotal net earnings per share - basic\n11.13\n5.84\n13.88\nContinuing operations - diluted\n11.03\n5.79\n5.20\nDiscontinued operations - diluted\n8.52\nTotal net earnings per share - diluted\n11.03\n5.79\n13.72\nAverage shares outstanding (Notes 1 and 15)\nBasic\n2,407.4\n2,407.3\n2,533.5\nDiluted\n2,429.4\n2,560.4\nSee Notes to Consolidated Financial Statements"}]

Derivation: {"current_value": 26804.0, "op": "pct_change", "previous_value": 14066.0}